Literature DB >> 1722493

Synthetic peptide conjugates with horseradish peroxidase and beta-galactosidase for use in epitope-specific immunocytochemistry and ELISA.

J D Laman1, A J van den Eertwegh, C Deen, N Vermeulen, W J Boersma, E Claassen.   

Abstract

Synthetic peptide-alkaline phosphatase conjugates can be used to detect the epitope specificity of (i) antibody-forming cells in vivo by immunocytochemistry; (ii) of antibody secreting cells in vitro by spot-ELISA; and (iii) antibodies in solution by capture ELISA. The availability of synthetic peptide-enzyme conjugates using detector enzymes other than alkaline phosphatase would offer several important advantages, for example in double staining approaches. This paper reports the production of synthetic peptide-horseradish peroxidase conjugates and synthetic peptide-beta-galactosidase conjugates. A peptide of 21 amino acids (SP 29) was coupled to peroxidase in seven differing molar ratios of peptide over peroxidase, ranging from 1:3.4 to 1:575, using periodate oxidation of the enzyme. SP 29 was coupled to beta-galactosidase in four molar ratios ranging from 1.25 to 10, using glutaraldehyde pre-activation of the enzyme. The enzyme activity of the different conjugates was determined, the conjugates were tested in direct capture-ELISA with peptide-specific monoclonal antibodies, and the conjugates were tested in immunocytochemistry to detect peptide-specific B cells. The results show that the conjugates perform best if the peptide is coupled to the enzyme at relatively low molar ratios (1-30). The availability of these new peptide-enzyme conjugates broadens the applicability of synthetic peptides for detection purposes in several assay systems.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722493     DOI: 10.1016/0022-1759(91)90304-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain.

Authors:  J D Laman; M M Schellekens; Y H Abacioglu; G K Lewis; M Tersmette; R A Fouchier; J P Langedijk; E Claassen; W J Boersma
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

2.  In vivo expression of interleukin-1 beta (IL-1 beta), IL-2, IL-4, IL-6, tumour necrosis factor-alpha and interferon-gamma in the fetal murine thymus.

Authors:  J Deman; M Van Meurs; E Claassen; C Humblet; J Boniver; M P Defresne
Journal:  Immunology       Date:  1996-09       Impact factor: 7.397

3.  Double-antigen enzyme-linked immunosorbent assay for detection of hepatitis E virus-specific antibodies in human or swine sera.

Authors:  Wei Ping Hu; Yang Lu; Nestor Amadeo Precioso; Hsiao Ying Chen; Teresa Howard; David Anderson; Ming Guan
Journal:  Clin Vaccine Immunol       Date:  2008-05-21

4.  Development of a novel peptide aptamer-based immunoassay to detect Zika virus in serum and urine.

Authors:  Do Thi Hoang Kim; Duong Tuan Bao; Hyun Park; Nguyen Minh Ngoc; Seon-Ju Yeo
Journal:  Theranostics       Date:  2018-06-07       Impact factor: 11.556

5.  Double-antigen sandwich ELISA based on chimeric antigens for detection of antibodies to Trypanosoma cruzi in human sera.

Authors:  Natália Erdens Maron Freitas; Emily Ferreira Santos; Leonardo Maia Leony; Ângelo Antônio Oliveira Silva; Ramona Tavares Daltro; Larissa de Carvalho Medrado Vasconcelos; Gabriela Agra Duarte; Cristiane Oliveira da Mota; Edimilson Domingos Silva; Paola Alejandra Fiorani Celedon; Nilson Ivo Tonin Zanchin; Fred Luciano Neves Santos
Journal:  PLoS Negl Trop Dis       Date:  2022-03-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.